Synthroid — Class III drug recall D-0088-2024
Ongoing recall by AbbVie Inc., reported 2023-11-15. Labeling: Wrong Barcode- One (1) of every forty (40) unit dose blister will contain incorrect barcode informat
| Recall number | D-0088-2024 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | AbbVie Inc., North Chicago, IL, United States |
| Recall initiated | 2023-10-17 |
| Classified | 2023-11-05 |
| Reported by FDA | 2023-11-15 |
| Quantity | 864 cartons |
| Reason classes | labeling |
| NDC | 00074-3727, 00074-3727-13, 00074-3727-19, 00074-3727-71, 00074-3727-72, 00074-3727-90, 00074-4341, 00074-4341-13, 00074-4341-19, 00074-4341-72, 00074-4341-90, 00074-4552, 00074-4552-11, 00074-4552-13, 00074-4552-19, 00074-4552-71, 00074-4552-72, 00074-4552-90, 00074-5182, 00074-5182-11, 00074-5182-13, 00074-5182-19, 00074-5182-71, 00074-5182-72, 00074-5182-90 and 47 more |
| Lot numbers | 1187435 |
| Expiration dates | 2024-02 |
Product
Synthroid, Levothyroxine Sodium Tablets, USP 125mcg (0.125mg), 100-count bottle, Rx Only AbbVie Inc. North Chicago, IL 60064, U.S.A. NDC 0074-7068-11
Reason for recall
Labeling: Wrong Barcode- One (1) of every forty (40) unit dose blister will contain incorrect barcode information that causes a 125mcg unit dose is scanned as 200mcg unit dose.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0088-2024. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.